Journal of Medical Toxicology

, Volume 9, Issue 2, pp 148–154 | Cite as

Opioid Receptor Polymorphism A118G Associated with Clinical Severity in a Drug Overdose Population

  • A. F. Manini
  • M. M. Jacobs
  • D. Vlahov
  • Y. L. Hurd
Toxicology Investigation


Genetic variations in the human mu-opioid receptor gene (OPRM1) mediate individual differences in response to pain and opiate addiction. We studied whether the common A118G (rs1799971) mu-opioid receptor single nucleotide polymorphism (SNP) was associated with overdose severity in humans. In addition, we examined an SNP responsible for alternative splicing of OPRM1 (rs2075572). We assessed allele frequencies of the above SNPs and associations with clinical severity in patients presenting to the emergency department (ED) with acute drug overdose. This work was designed as an observational cohort study over a 12-month period at an urban teaching hospital. Participants consisted of consecutive adult ED patients with suspected acute drug overdose for whom discarded blood samples were available for analysis. Specimens were linked with clinical variables (demographics, urine toxicology screens, clinical outcomes) then deidentified prior to genetic SNP analysis. Blinded genotyping was performed after standard DNA purification and whole genome amplification. In-hospital severe outcomes were defined as either respiratory arrest (RA; defined by mechanical ventilation) or cardiac arrest (CA; defined by loss of pulse). We analyzed 179 patients (61% male, median age 32) who overall suffered 15 RAs and four CAs, of whom three died. The 118G allele conferred 5.3-fold increased odds of CA/RA (p<0.05), while the rs2075572 variant allele was not associated with CA/RA. The 118G variant allele in the OPRM1 gene is associated with worse clinical severity in patients with acute drug overdose. These findings mark the first time that the 118G variant allele is linked with clinical drug overdose vulnerability.


Opioid receptor Polymorphism Overdose Addiction Cardiac arrest 


  1. 1.
    Warner M, Chen LH, Makuc DM, Anderson RN, Miniño AM (2011) Drug poisoning deaths in the United States, 1980–2008. NCHS data brief, no 81. Hyattsville, MD: National Center for Health StatisticsGoogle Scholar
  2. 2.
    Centers for Disease Control and Prevention. WONDER [Online]. (2007) Centers for Disease Control and Prevention. Available at: Accessed June 1, 2012
  3. 3.
    Paulozzi LJ, Budnitz DS, Xi Y (2006) Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiol Drug Saf 15:618–627PubMedCrossRefGoogle Scholar
  4. 4.
    Hall AJ, Logan JE, Toblin RL et al (2008) Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA 300:2613–2620PubMedCrossRefGoogle Scholar
  5. 5.
    Paulozzi LJ, Jones CM, Mack KA, et al (2011) Vital Signs: overdoses of prescription opioid pain relievers – United States, 1999–2008. MMWR Vol 60 No 43Google Scholar
  6. 6.
    Polomano RC, Gelnett CM, Heffner SM et al (2001) Evidence for opioid variability: Part 1. A biological perspective. Semin Perioper Nurs 10:3–16PubMedGoogle Scholar
  7. 7.
    Polomano RC, Heffner SM, Reck DL, Gelnett CM, French D (2001) Evidence for opioid variability: Part 2. Psychosocial influences. Semin Perioper Nurs 10:159–166PubMedGoogle Scholar
  8. 8.
    Bond C, LaForge KS, Tian M et al (1998) Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. Proc Natl Acad Sci 95:9608–9613PubMedCrossRefGoogle Scholar
  9. 9.
    Beyer A, Koch T, Schroder H, Schulz S, Hollt V (2004) Effect of the A118G polymorphism on binding affinity, potency and agonist-mediated endocytosis, desensitization, and resensitization of the human mu-opioid receptor. J Neurochem 89:553–560PubMedCrossRefGoogle Scholar
  10. 10.
    Tan EC, Tan CH, Karupathivan U, Yap EP (2003) Mu opioid receptor gene polymorphisms and heroin dependence in Asian populations. Neuroreport 14(4):569–572PubMedCrossRefGoogle Scholar
  11. 11.
    Klepstad P, Rakvag TT, Kaasa S et al (2004) The 118 AG polymorphism in the human micro-opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease. Acta Anaesthesiol Scand 48:1232–1239PubMedCrossRefGoogle Scholar
  12. 12.
    Chou WY, Yang LC, Lu H et al (2006) Association of mu-opioid receptor gene polymorphism (A118G) with variations in morphine consumption for analgesia after total knee arthroplasty. Acta Anaesthesiol Scand 50:787–792PubMedCrossRefGoogle Scholar
  13. 13.
    Fillingim RB, Kaplan L, Staud R et al (2005) The A118G single nucleotide polymorphism of the mu-opioid receptor gene (OPRM1) is associated with pressure pain sensitivity in humans. J Pain 6:159–167PubMedCrossRefGoogle Scholar
  14. 14.
    OPRM1, Unigene Database. Available: Accessed on August 6, 2012
  15. 15.
    Shabalina SA, Zaykin DV, Gris P et al (2009) Expansion of the human mu-opioid receptor gene architecture: novel functional variants. Hum Mol Gen 18(6):1037–1051PubMedCrossRefGoogle Scholar
  16. 16.
    Pasternak DA, Pan L, Xu J et al (2004) Identification of three new alternatively spliced variants of the rat mu opioid receptor gene: dissociation of affinity and efficacy. J Neurochem 91:881–890PubMedCrossRefGoogle Scholar
  17. 17.
    Schuller AG, King MA, Zhang J et al (1999) Retention of heroin and morphine-6 beta-glucuronide analgesia in a new line of mice lacking exon 1 of MOR-1. Nat Neurosci 2:151–156PubMedCrossRefGoogle Scholar
  18. 18.
    Zhang L, Kendler KS, Chen X (2006) The mu-opioid receptor gene and smoking initiation and nicotine dependence. Behav Brain Funct 2(28):1–6Google Scholar
  19. 19.
    Gilbert EH, Lowenstein SR, Koziol J, Barta DC, Steiner J (1996) Chart reviews in emergency medicine research: where are the methods? Ann Emerg Med 27:305–308PubMedCrossRefGoogle Scholar
  20. 20.
    Hernandez-Avila CA, Wand G, Luo X et al (2003) Association between the cortisol response to opioid blockade and the Asn40Asp polymorphism at the mu-opioid receptor locus (OPRM1). Am J Med Genet B Neuropsychiatr Genet 118B:60–65PubMedCrossRefGoogle Scholar
  21. 21.
    Wand GS, McCaul M, Yang X et al (2002) The mu-opioid receptor gene polymorphism (A118G) alters HPA axis activation induced by opioid receptor blockade. Neuropsychopharmacology 26:106–114PubMedCrossRefGoogle Scholar
  22. 22.
    Purcell S, Neale B, Todd-Brown K et al (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81(3):559–575PubMedCrossRefGoogle Scholar
  23. 23.
    Oslin DW, Berrettini W, Kranzler HR et al (2003) A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients. Neuropsychopharmacology 28:1546–1552PubMedCrossRefGoogle Scholar
  24. 24.
    Anton RF, Oroszi G, O’Malley S et al (2008) An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence. Arch Gen Psychiatry 65(2):135–144PubMedCrossRefGoogle Scholar
  25. 25.
    Sora I, Takahashi N, Funada M et al (1997) Opiate receptor knockout mice define mu receptor roles in endogenous nociceptive responses and morphine-induced analgesia. Proc Natl Acad Sci 94:1544–1549PubMedCrossRefGoogle Scholar
  26. 26.
    Ray LA, Barr CS, Blendy JA, Oslin D, Goldman D, Anton RF (2012) The role of the Asn40Asp polymorphism of the mu opioid receptor gene (OPRM1) on alcoholism etiology and treatment: a critical review. Alcohol Clin Exp Res 36:385–394PubMedCrossRefGoogle Scholar
  27. 27.
    Proudnikov D, Randesi M, Levran O et al (2012) Association of polymorphisms of the mu opioid receptor gene with the severity of HIV infection and response to HIV treatment. J Infect Dis 205(11):1745–1756PubMedCrossRefGoogle Scholar
  28. 28.
    Bortsov AV, Millikan RC, Belfer I, Boortz-Marx RL, Arora H, McLean SA (2012) μ-Opioid receptor gene A118G polymorphism predicts survival in patients with breast cancer. Anesthesiology 116(4):896–902PubMedCrossRefGoogle Scholar
  29. 29.
    Arias AJ, Chan G, Gelernter J, Farrer L, Kranzler HR (2012) Variation in OPRM1 and risk of suicidal behavior in drug-dependent individuals. Am J Addict 21(1):5–10PubMedCrossRefGoogle Scholar
  30. 30.
    Hishimoto A, Cui H, Mouri K et al (2008) A functional polymorphism of the micro-opioid receptor gene is associated with completed suicides. J Neural Transm 115:531–536PubMedCrossRefGoogle Scholar
  31. 31.
    Tan E, Lim E, Teo Y, Lim Y, Law H, Sia A (2009) Ethnicity and OPRM variant independently predict pain perception and patient-controlled analgesia usage for post-operative pain. Mol Pain 5(32):1–8Google Scholar

Copyright information

© American College of Medical Toxicology 2013

Authors and Affiliations

  • A. F. Manini
    • 1
  • M. M. Jacobs
    • 2
  • D. Vlahov
    • 3
  • Y. L. Hurd
    • 2
  1. 1.Division of Medical Toxicology, Department of Emergency Medicine, Mount Sinai School of MedicineElmhurst Hospital CenterNew YorkUSA
  2. 2.Departments of Psychiatry and NeuroscienceMount Sinai School of MedicineNew YorkUSA
  3. 3.School of NursingUniversity of CaliforniaSan FranciscoUSA

Personalised recommendations